Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001402

Drug Information
NameMitomycin C    
SynonymsD00208; BSPBio_001267; KBio2_005743; KBio3_001073; CBiol_001927; Mutamycin; CHEBI:27504; BRD-K59670716-001-02-6; Mitomycine [INN-French]; Mitomycinum C; Mytozytrex; Bio1_001191; Ametycin; KBio2_000607; M4287_SIGMA; C06681; CHEMBL105; 50-07-7; Mitamycin; NSC 26980; C15H18N4O5; HMS1362O09; LS-136; Mitomycin C (JP15); Mitomycine; KBioSS_000607; UNII-50SG953SK6; 74349-48-7; Mitomycin C from Streptomyces caespitosus; NSC-26980; AC1L1L1Q; Ametycine; Mitomycin [USAN:INN:BAN]; CID5746; mitomycin C; EINECS 200-008-6; M0440_SIGMA; Mitomycin; Mitomycyna C; Mitomicina [INN-Spanish]; Muamycin; HMS1792O09; Mitomycinum; Mitomycinum [INN-Latin]; Bio1_000213; Bio1_000702; Mit-C; CCRIS 414; KBio2_003175; Muamycin (TN); Ambotz50-07-7; MLS001332654; Mitomycin (USP/INN); DB00305; 1404-00-8; M0503_SIGMA; Mitomycin C, Streptomyces caespitosus, Carrier-Free; 7481-68-7; Mitomycin-C; SMP1_000307; Mito-C; Mitozytrex; Mytomycin; HMS1990O09; 7-Amino-9alpha-methoxymitosane; MMC; Mitomycins; Mitocin C; NCI-C04706; Mitomycyna C [Polish]; HMS2089F16; SMR000058401; Mitomycin (TN); Mitomicina; MolPort-003-938-644; Mitocin-C; NCGC00163468-02; RCRA waste number U010; AI3-26199; Bio2_000464; HSDB 3239; Mitomycin C, Streptomyces caespitosus; nchembio.559-comp7; RCRA waste no. U010; Bio2_000944; IDI1_002219; LS-173087; KBio3_001074; KBioGR_000607; 144085-53-0    
IndicationCancersApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntineoplastic Agents    
CAS NumberCAS 50-07-7
FormularC15H18N4O5    
PubChem Compound IDCID 5746.    
PubChem Substance IDSID 8906.    
ChEBI27504;    
SuperDrug ATC IDL01DC03;    
SuperDrug CAS ID000050077;    
TargetDNAAdduct[2]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Structural studies of atom-specific anticancer drugs acting on DNA. Pharmacol Ther. 1999 Sep;83(3):181-215. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543